Cargando…
International validation of a urinary biomarker panel for identification of active lupus nephritis in children
BACKGROUND: Conventional markers of juvenile-onset systemic lupus erythematosus (JSLE) disease activity fail to adequately identify lupus nephritis (LN). While individual novel urine biomarkers are good at detecting LN flares, biomarker panels may improve diagnostic accuracy. The aim of this study w...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203828/ https://www.ncbi.nlm.nih.gov/pubmed/27590021 http://dx.doi.org/10.1007/s00467-016-3485-3 |
_version_ | 1782489796189356032 |
---|---|
author | Smith, Eve Mary Dorothy Jorgensen, Andrea Lyn Midgley, Angela Oni, Louise Goilav, Beatrice Putterman, Chaim Wahezi, Dawn Rubinstein, Tamar Ekdawy, Diana Corkhill, Rachel Jones, Caroline Ann Marks, Stephen David Newland, Paul Pilkington, Clarissa Tullus, Kjell Beresford, Michael William |
author_facet | Smith, Eve Mary Dorothy Jorgensen, Andrea Lyn Midgley, Angela Oni, Louise Goilav, Beatrice Putterman, Chaim Wahezi, Dawn Rubinstein, Tamar Ekdawy, Diana Corkhill, Rachel Jones, Caroline Ann Marks, Stephen David Newland, Paul Pilkington, Clarissa Tullus, Kjell Beresford, Michael William |
author_sort | Smith, Eve Mary Dorothy |
collection | PubMed |
description | BACKGROUND: Conventional markers of juvenile-onset systemic lupus erythematosus (JSLE) disease activity fail to adequately identify lupus nephritis (LN). While individual novel urine biomarkers are good at detecting LN flares, biomarker panels may improve diagnostic accuracy. The aim of this study was to assess the performance of a biomarker panel to identify active LN in two international JSLE cohorts. METHODS: Novel urinary biomarkers, namely vascular cell adhesion molecule-1 (VCAM-1), monocyte chemoattractant protein 1 (MCP-1), lipocalin-like prostaglandin D synthase (LPGDS), transferrin (TF), ceruloplasmin, alpha-1-acid glycoprotein (AGP) and neutrophil gelatinase-associated lipocalin (NGAL), were quantified in a cross-sectional study that included participants of the UK JSLE Cohort Study (Cohort 1) and validated within the Einstein Lupus Cohort (Cohort 2). Binary logistic regression modelling and receiver operating characteristic curve analysis [area under the curve (AUC)] were used to identify and assess combinations of biomarkers for diagnostic accuracy. RESULTS: A total of 91 JSLE patients were recruited across both cohorts, of whom 31 (34 %) had active LN and 60 (66 %) had no LN. Urinary AGP, ceruloplasmin, VCAM-1, MCP-1 and LPGDS levels were significantly higher in those patients with active LN than in non-LN patients [all corrected p values (p (c)) < 0.05] across both cohorts. Urinary TF also differed between patient groups in Cohort 2 (p (c) = 0.001). Within Cohort 1, the optimal biomarker panel included AGP, ceruloplasmin, LPGDS and TF (AUC 0.920 for active LN identification). These results were validated in Cohort 2, with the same markers resulting in the optimal urine biomarker panel (AUC 0.991). CONCLUSION: In two international JSLE cohorts, urinary AGP, ceruloplasmin, LPGDS and TF demonstrate an ‘excellent’ ability for accurately identifying active LN in children. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00467-016-3485-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5203828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-52038282017-01-13 International validation of a urinary biomarker panel for identification of active lupus nephritis in children Smith, Eve Mary Dorothy Jorgensen, Andrea Lyn Midgley, Angela Oni, Louise Goilav, Beatrice Putterman, Chaim Wahezi, Dawn Rubinstein, Tamar Ekdawy, Diana Corkhill, Rachel Jones, Caroline Ann Marks, Stephen David Newland, Paul Pilkington, Clarissa Tullus, Kjell Beresford, Michael William Pediatr Nephrol Original Article BACKGROUND: Conventional markers of juvenile-onset systemic lupus erythematosus (JSLE) disease activity fail to adequately identify lupus nephritis (LN). While individual novel urine biomarkers are good at detecting LN flares, biomarker panels may improve diagnostic accuracy. The aim of this study was to assess the performance of a biomarker panel to identify active LN in two international JSLE cohorts. METHODS: Novel urinary biomarkers, namely vascular cell adhesion molecule-1 (VCAM-1), monocyte chemoattractant protein 1 (MCP-1), lipocalin-like prostaglandin D synthase (LPGDS), transferrin (TF), ceruloplasmin, alpha-1-acid glycoprotein (AGP) and neutrophil gelatinase-associated lipocalin (NGAL), were quantified in a cross-sectional study that included participants of the UK JSLE Cohort Study (Cohort 1) and validated within the Einstein Lupus Cohort (Cohort 2). Binary logistic regression modelling and receiver operating characteristic curve analysis [area under the curve (AUC)] were used to identify and assess combinations of biomarkers for diagnostic accuracy. RESULTS: A total of 91 JSLE patients were recruited across both cohorts, of whom 31 (34 %) had active LN and 60 (66 %) had no LN. Urinary AGP, ceruloplasmin, VCAM-1, MCP-1 and LPGDS levels were significantly higher in those patients with active LN than in non-LN patients [all corrected p values (p (c)) < 0.05] across both cohorts. Urinary TF also differed between patient groups in Cohort 2 (p (c) = 0.001). Within Cohort 1, the optimal biomarker panel included AGP, ceruloplasmin, LPGDS and TF (AUC 0.920 for active LN identification). These results were validated in Cohort 2, with the same markers resulting in the optimal urine biomarker panel (AUC 0.991). CONCLUSION: In two international JSLE cohorts, urinary AGP, ceruloplasmin, LPGDS and TF demonstrate an ‘excellent’ ability for accurately identifying active LN in children. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00467-016-3485-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-09-03 2017 /pmc/articles/PMC5203828/ /pubmed/27590021 http://dx.doi.org/10.1007/s00467-016-3485-3 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Smith, Eve Mary Dorothy Jorgensen, Andrea Lyn Midgley, Angela Oni, Louise Goilav, Beatrice Putterman, Chaim Wahezi, Dawn Rubinstein, Tamar Ekdawy, Diana Corkhill, Rachel Jones, Caroline Ann Marks, Stephen David Newland, Paul Pilkington, Clarissa Tullus, Kjell Beresford, Michael William International validation of a urinary biomarker panel for identification of active lupus nephritis in children |
title | International validation of a urinary biomarker panel for identification of active lupus nephritis in children |
title_full | International validation of a urinary biomarker panel for identification of active lupus nephritis in children |
title_fullStr | International validation of a urinary biomarker panel for identification of active lupus nephritis in children |
title_full_unstemmed | International validation of a urinary biomarker panel for identification of active lupus nephritis in children |
title_short | International validation of a urinary biomarker panel for identification of active lupus nephritis in children |
title_sort | international validation of a urinary biomarker panel for identification of active lupus nephritis in children |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203828/ https://www.ncbi.nlm.nih.gov/pubmed/27590021 http://dx.doi.org/10.1007/s00467-016-3485-3 |
work_keys_str_mv | AT smithevemarydorothy internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT jorgensenandrealyn internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT midgleyangela internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT onilouise internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT goilavbeatrice internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT puttermanchaim internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT wahezidawn internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT rubinsteintamar internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT ekdawydiana internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT corkhillrachel internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT jonescarolineann internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT marksstephendavid internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT newlandpaul internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT pilkingtonclarissa internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT tulluskjell internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren AT beresfordmichaelwilliam internationalvalidationofaurinarybiomarkerpanelforidentificationofactivelupusnephritisinchildren |